Chandler-based drug manufacturer Insys Therapeutics, infamous for the questionable marketing practices of its highly-addictive opioid fentanyl spray Subsys, announced plans to sell off assets to Wyoming-based BTcP Pharma and London-based Hikma Pharmaceuticals in a series of U.S. Securities and Exchange Commission filings.
After...
